Nobivac® Lyme is a bacterin that contains two inactivated strains of Borrelia burgdorferi comprised of outer surface protein A (OspA) and outer surface protein C (OspC). It is adjuvanted to elicit an immune response. This bacterin is approved for the vaccination of healthy dogs as an aid in the prevention of subclinical arthritis caused by B. burgdorferi.
Lyme is administered subcutaneously as an initial vaccination followed by a booster 2 to 4 weeks later. It can be given to dogs beginning at 8 weeks of age. Annual re-vaccination with Nobivac ®
Lyme is recommended.
*Nobivac® Lyme aids in the prevention of subclinical arthritis caused by Borrelia burgdorferi.